deferoxamine has been researched along with Nephrolithiasis in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Nephrolithiasis: Formation of stones in the KIDNEY.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this report, we describe two pediatric patients diagnosed with nephrolithiasis while undergoing treatment with the chelating agents deferasirox, deferiprone, and deferoxamine for iron overload secondary to repeat blood transfusion." | 4.31 | Nephrolithiasis in two patients on iron chelation therapy: A case report. ( Baker, Z; Dillon, H; Pena, A; Sparks, S; Syed, H; Wang, Y, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dillon, H | 1 |
| Baker, Z | 1 |
| Pena, A | 1 |
| Wang, Y | 1 |
| Syed, H | 1 |
| Sparks, S | 1 |
| Ricchi, P | 1 |
| Ammirabile, M | 1 |
| Costantini, S | 1 |
| Spasiano, A | 1 |
| Di Matola, T | 1 |
| Cinque, P | 1 |
| Casale, M | 1 |
| Filosa, A | 1 |
| Prossomariti, L | 1 |
2 other studies available for deferoxamine and Nephrolithiasis
| Article | Year |
|---|---|
Nephrolithiasis in two patients on iron chelation therapy: A case report.
Topics: Benzoates; beta-Thalassemia; Chelation Therapy; Child; Deferasirox; Deferiprone; Deferoxamine; Human | 2023 |
Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters.
Topics: Adult; Aging; Benzoates; beta-Thalassemia; Chelation Therapy; Deferasirox; Deferoxamine; Disease Sus | 2014 |